Home

Our Company

Aspiring to be the global leader in DDR-targeted cancer therapies

OUR COMPANY

Our Pipeline

Pioneering the development of therapeutics to modulate DNA Damage Response

OUR PIPELINE

Our Science

Revolutionizing the future of cancer therapy

OUR SCIENCE

our clinical trials

Empowering novel cancer treatment options

OUR CLINICAL TRIALS

Investors & Media

Achieving success through high standards of performance and conduct

INVESTORS & MEDIA